US Stock MarketDetailed Quotes
MIRA MIRA Pharmaceuticals
- 1.430
- +0.140+10.85%
Close Dec 2 16:00 ET
- 1.493
- +0.063+4.38%
Pre 08:16 ET
23.68MMarket Cap-2069P/E (TTM)
1.440High1.270Low821.81KVolume1.270Open1.290Pre Close1.11MTurnover7.50%Turnover RatioLossP/E (Static)16.56MShares5.01052wk High6.62P/B15.68MFloat Cap0.51052wk Low--Dividend TTM10.96MShs Float7.980Historical High--Div YieldTTM13.18%Amplitude0.510Historical Low1.349Avg Price1Lot Size
About MIRA Pharmaceuticals Company
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.
Company Profile
SymbolMIRA
Company NameMIRA Pharmaceuticals
Listing DateAug 3, 2023
Issue Price7.00
Founded2020
CEOMr. Erez Aminov
MarketNASDAQ
Employees3
Fiscal Year Ends12-31
Address1200 Brickell Avenue,Suite 1950 1183
CityMiami
ProvinceFlorida
CountryUnited States of America
Zip Code33131
Phone1-786-432-9792
Company Executives
- Name
- Position
- Salary
- Erez Aminov
- Chairman of the Board and Chief Executive Officer
- 1.67M
- Michelle Yanez, M.B.A.
- Chief Financial Officer, Secretary, Treasurer and Principal Accounting Officer
- 541.62K
- Dr. Denil Nanji Shekhat, M.D.
- Director
- --
- Ned MacPherson
- Director
- --
- Matthew Pratt Whalen
- Director
- --
- Dr. Matthew Paul Del Giudice, M.D.
- Director
- --
- Edward MacPherson
- Independent Director
- --
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
